Charles Keller Lab
The Keller Laboratory studies the driving mechanisms and therapeutic targets in the childhood muscle cancers, alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma, and the childhood brain tumor, medulloblastoma.
Latest from the Keller Lab Blog
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcomaWe hope you will enjoy this review and commentary as much as we do. A lot of people in pharma, the community-at-large and scientific thought leaders helped to create this somewhat out of the box concept proposal. With some additional community volunteers, I think we could really put this plan to action. Sincerely, Charles
[ This review was made possible by a gift from the Ethan Jostad Foundation ].